Magnetic Resonance Image Guided Radiotherapy (MRIgRT) course

Key information 

Next course dates

22-23 September 2025, closing date for registrations 18th August 2025

Location

BLB Sutton, SM2 5PT
See Sutton map at the bottom of our contacts page.

This course is organised by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.

Registration form


Course outline

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading practitioners in the field, develop skills and share knowledge with other professionals involved in MRI in radiotherapy. 

This two day course aims to improve understanding of MRIgRT, focusing on the knowledge and skills required to support current and future needs in radiotherapy.

The development of MRI in radiotherapy planning involves close communication with radiology and radiotherapy professionals. This course is aimed at all professionals involved in or interested in MRI for radiotherapy, including radiographers, physicists and clinicians.

Course Organisers: Professor Helen McNair, Ms Erica Scurr, Dr Shaista Hafeez, Miss Trina Herbert, and Professor Uwe Oelfke 

"Great overall knowledge for all professions interested in MRI - extremely informative."
– Therapeutic Radiographer and course attendee

Course overview

The course will include taught and practical workshops to:

  • Improve understanding of the basic principles of MRI
  • Build foundation skills to support the increase in demand for MRI simulation
  • Develop practical skills
  • Learn about current clinical pathways and the latest research developments 

The practical demonstrations will include: 

  • MR simulation, image acquisition and interpretation, RT set up and safety. 
  • Sequence and parameter manipulation 
  • Adaptive workflow on the MR Linac 

Provisional lecture list 

  • The clinical need for MR in radiotherapy
  • Image contrast, Resolution and Factors affecting signal-to-noise
  • MR Simulation
  • MR planning workflow
  • MR-CT fusion planning
  • Image fusion and dosimetry
  • Safety considerations
  • Regional MR in RT – Pelvis,
  • Regional MR in RT, Abdomen (liver and pancreas)
  • Regional MR in RT, Breast
  • Managing motion (4D)
  • MR in Brachytherapy
  • MR Linac QA
  • Diffusion Weighted Imaging (DWI) principles and applications
  • Functional imaging

Programme draft

Previous comments from attendees

“I have now significantly more knowledge of potential for MRI in radiotherapy, its benefits and drawbacks.”   Clinical Oncologist

“MRI in radiotherapy planning is a lot more complicated than I thought. Highlighted that we would be crazy to do more MRI without an MRI physicist in the trust.”   Radiotherapy Physicist

“Excellent overview of MRI and how it is and will be used in the future.”  Radiotherapy Physicist

“Collaboration between diagnostic and Therapy radiographers is vital in MR planning.”   Therapeutic Radiographer

IPEM approved logoCPD now logo

 

 

Accommodation

Accommodation is available in local hotels, details can be supplied upon request. 

Further information

For further details on up to date course content call +44 (0)20 8661 3704 or email Cheryl Taylor.

Latest ICR News

Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spread

30/07/25

A collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously unidentified fragments called shearosomes as tumour cells squeeze through narrow blood vessels. Shearosomes appear to actively influence their surroundings, supporting the growth of secondary tumours, offering new insights into how cancer spreads.
Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA research

29/07/25 - Robbie Lockyer

Two decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor Alan Ashworth, then Director of the Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research, London, and his collaborator Professor Steve Jackson had long known that inherited genetic mutations in the genes BRCA1 and BRCA2 increase the risk of cancer. But, they wondered, what if those same mutations could be turned against the cancer itself?
Breast cancer cells (stained with anti-cytokeratin - green) invading through a layer of fibroblasts (stained for actin - red). Nuclei were counterstained with DAPI - blue
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment

18/07/25

Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting treatment.
A picture of a radiotherapy machine in a hospital
Targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

15/07/25

Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.